D. Zlotoff

Immune Responses in Checkpoint Inhibitor–Associated Cardiovascular Immune–Related Adverse Events

Although immune checkpoint inhibitors have improved cancer outcomes, their use can trigger autoimmune toxicities affecting essentially any organ system. In the cardiovascular system, these immune-related adverse events can manifest as myocarditis, pericarditis, accelerated atherosclerosis, vasculitis, arrhythmias, and...